Please use this identifier to cite or link to this item:
Scopus Web of Science® Altmetric
Type: Journal article
Title: Proteins' promise - progress and challenges in ovarian cancer proteomics
Author: Koehn, H.
Oehler, M.
Citation: Menopause International (Print Edition), 2007; 13(4):148-153
Publisher: Royal Society of Medicine Press Ltd.
Issue Date: 2007
ISSN: 1754-0453
Statement of
H Koehn and M K Oehler
Abstract: Ovarian cancer is the leading cause of gynaecological cancer death. The mortality rate of ovarian cancer could be greatly decreased if there were a screening test which was able to detect the disease at an early stage, resulting in an increased probability of cure. The most promising prospect for the early detection of ovarian cancer comes from the rapidly advancing field of clinical proteomics. An increasing number of reports on the potential clinical application of proteomics research for early detection as well as risk assessment and management of ovarian cancer are being published. Although the research is very promising, major technical challenges are still preventing new discoveries in ovarian cancer proteomics from being translated into clinical practice.
Keywords: Humans; Ovarian Neoplasms; Disease Progression; Neoplasm Proteins; Proteome; Mass Screening; Risk Assessment; Proteomics; Women's Health; Female; Biomarkers, Tumor
Description: Copyright © 2007 British Menopause Society
RMID: 0020076841
DOI: 10.1258/175404507783004159
Appears in Collections:Obstetrics and Gynaecology publications

Files in This Item:
There are no files associated with this item.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.